» » »

Colcrys for Acute Gout Cary NC

Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders. The drug's active ingredient, colchicine, is derived from the dried seeds of the autumn crocus plant.

Chiropractic Partners
(919) 467-7797
1125 Kildaire Farm Rd
Cary, NC

Data Provided by:
Kildaire Animal Medical Center
(919) 469-8086
1409 Kildaire Farm Rd.
Cary, NC

Data Provided by:
Cat Clinic Of Cary
(919) 469-9000
2464 SW Cary Pkwy
Cary, NC

Data Provided by:
Milham Family Chiropractic
(919) 238-7540
900 W Williams St
Apex, NC

Data Provided by:
Roger B. Russell
(919) 785-0505
3633 Harden Road
Raleigh, NC
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
Mudryk Family-Chiropractic, PA
(919) 238-7736
401 Keisler Dr. Suite 100
Cary, NC

Data Provided by:
Team Chiropractic & Sports Medicine - Cary
(919) 650-2447
258 Towne Village Drive
Cary, NC

Data Provided by:
Mayfair Animal Hospital
(919) 467-6146
1130 SW Maynard Rd
Cary, NC

Data Provided by:
Chiropractic First Pllc
(919) 443-1851
1011 West Williams St. Ste 104
Apex, NC

Data Provided by:
Glenn M Davis
(919) 785-1220
2304 Wesvill Court
Raleigh, NC
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
Data Provided by:

Colcrys for Acute Gout

Provided By:

Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders. The drug's active ingredient, colchicine, is derived from the dried seeds of the autumn crocus plant.

In a news release, the agency said colchicine has been used as a remedy to treat acute gout flares "for many years," despite that it hadn't been FDA approved. The agency said it was in the midst of a program to bring other similarly unapproved products under its regulatory authority.

A dosing study required for approval led the agency to recommend a lower dosing regimen for Colcrys that had been commonly prescribed, the news release said. This was designed to prevent gastrointestinal problems.

The FDA said it was alerting healthcare professionals of the lower dosing schedule and also warning that the drug had the potential for severe interactions with other medications.

FMF, common in Mediterranean nations but less so in the United States, has symptoms including fever, arthritis, and inflammation of the lining of the lungs and abdomen. Colcrys is now the first drug that's been FDA-approved to treat FMF, the agency said.

The drug is produced by Philadelphia-based Mutual Pharmaceutical Company Inc.

More information

The FDA has more about this medication's approval.

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com